We are live on
!
Find out more
BP
Ballentine Partners Portfolio holdings
AUM
$8.18B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
-15.76%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$2.83B
AUM Growth
-$365M
(-11%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
5.53%
Top 10 Holdings %
Top 10 Hldgs %
63.82%
Holding
492
New
23
Increased
173
Reduced
193
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$38M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$38M |
| 3 |
Vanguard Morningstar Mid-Cap Growth ETF
VOT
|
+$21.1M |
| 4 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$14.9M |
| 5 |
iShares Core MSCI Europe ETF
IEUR
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$18M |
| 2 |
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
|
+$8.08M |
| 3 |
iShares Gold Trust
IAU
|
+$1.39M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$1.37M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.59% |
| 2 | Healthcare | 2.1% |
| 3 | Financials | 2.01% |
| 4 | Consumer Discretionary | 1.12% |
| 5 | Consumer Staples | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Boston Scientific
BSX
$71.1B
| $224K | 0.01% |
6,011
+107
| +2% | +$4.36K |
|
377
Northern Trust
NTRS
$33.4B
| $224K | 0.01% |
2,325
-143
| -6% | -$15.1K |
|
378
Sherwin-Williams
SHW
$87.8B
| $224K | 0.01% |
1,000
-112
| -10% | -$28.7K |
|
379
CBRE Group
CBRE
$43.7B
| $223K | 0.01% |
3,034
-183
| -6% | -$14.7K |
|
380
The Mosaic Company
MOS
$7.22B
| $221K | 0.01% |
4,686
+733
| +19% | +$44.9K |
|
381
Simon Property Group
SPG
$73.3B
| $221K | 0.01% |
2,330
+474
| +26% | +$54.3K |
|
382
Aptiv
APTV
$10.1B
| $220K | 0.01% |
+2,467
| New | +$252K |
|
383
Quanta Services
PWR
$104B
| $220K | 0.01% |
1,745
-3
| -0.2% | -$368 |
|
384
Copart
CPRT
$27.2B
| $219K | 0.01% |
+8,056
| New | +$229K |
|
385
Dollar Tree
DLTR
$25.1B
| $219K | 0.01% |
1,403
-454
| -24% | -$71.9K |
|
386
Altria Group
MO
$114B
| $219K | 0.01% |
5,228
-108
| -2% | -$5.59K |
|
387
Unum
UNM
$14.5B
| $217K | 0.01% |
6,384
-2,170
| -25% | -$73.4K |
|
388
JD.com
JD
$44.5B
| $216K | 0.01% |
+3,369
| New | +$194K |
|
389
Healthpeak Properties
DOC
$14.9B
| $215K | 0.01% |
8,259
-1,399
| -14% | -$42.4K |
|
390
ICICI Bank
IBN
$109B
| $215K | 0.01% |
12,119
-866
| -7% | -$16.2K |
|
391
iShares ESG Optimized MSCI USA ETF
SUSA
$4.16B
| $215K | 0.01% |
2,660
| – | – |
|
392
Capital One
COF
$136B
| $211K | 0.01% |
2,023
+236
| +13% | +$28.9K |
|
393
Darling Ingredients
DAR
$9.56B
| $210K | 0.01% |
3,498
+105
| +3% | +$7.97K |
|
394
Fluor
FLR
$7.2B
| $209K | 0.01% |
8,587
+44
| +0.5% | +$1.18K |
|
395
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
| $209K | 0.01% |
+1,633
| New | +$214K |
|
396
Cognizant
CTSH
$25.3B
| $208K | 0.01% |
3,063
-1,114
| -27% | -$85.3K |
|
397
Consolidated Edison
ED
$40B
| $207K | 0.01% |
+2,185
| New | +$208K |
|
398
Regeneron Pharmaceuticals
REGN
$78.3B
| $206K | 0.01% |
348
-30
| -8% | -$19.5K |
|
399
Tenaris
TS
$29.3B
| $205K | 0.01% |
7,981
-3,248
| -29% | -$100K |
|
400
Dominion Energy
D
$60.9B
| $204K | 0.01% |
2,560
-71
| -3% | -$5.86K |
|
Similar funds
LGF
CCM
WJWM
WA
CCM
AIM
FIA
VIM
Ballentine Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Ballentine Partners held 492 positions worth $2.83B, down 11% from $3.19B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Ballentine Partners deployed $156M of net new capital in Q2 2022, opening 23 new positions and adding to 173 existing holdings. Its largest new stake was Harbor Dividend Growth Leaders ETF: 384,894 shares worth $4.61M.
By sector, the portfolio is most concentrated in Technology at 3.6% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $18M trimmed.
- Ballentine Partners's largest Q2 2022 buy was Harbor Dividend Growth Leaders ETF: 384,894 shares worth $4.61M.
- Ballentine Partners added most to iShares Core S&P Total US Stock Market ETF in Q2 2022, an estimated $38M increase.
- Ballentine Partners's biggest Q2 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $18M.
- Ballentine Partners fully exited Vanguard Tax-Exempt Bond Index Fund in Q2 2022, selling an estimated $548K.
- Ballentine Partners's ten largest holdings make up 64% of its $2.83B portfolio in Q2 2022.
- Ballentine Partners opened 23 new positions and closed 56 in Q2 2022.
- Ballentine Partners's portfolio value fell 11% quarter-over-quarter to $2.83B.
Based on Ballentine Partners's 13F filing for Q2 2022, filed 9 Aug 2022.